Predictive oncology validates discovery 21 proof-of-concept campaign

Predictive oncology's discovery 21 campaign evaluated the ability of its pedal® platform to make high-confidence predictions in ovarian tumor samples. subsequent validation confirmed the accuracy and reproducibility of these predictions. predictive oncology's discovery 21 campaign evaluated the ability of its pedal® platform to make high-confidence predictions in ovarian tumor samples. subsequent validation confirmed the accuracy and reproducibility of these predictions.
POAI Ratings Summary
POAI Quant Ranking